Zobrazeno 1 - 10 of 48 pro vyhledávání: '"Millie, Long"'
1
Akademický článek
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial
Autor: Jordan Axelrad, Millie Long, Sara Horst, Anita Afzali, Tamar Sapir, Kristina Fajardo, Kara De Felice, Robert Sandler, Raymond Cross
Publikováno v: JMIR Research Protocols, Vol 11, Iss 12, p e40382 (2022)
BackgroundInflammatory bowel diseases (IBDs) are chronic inflammatory conditions of the gastrointestinal tract. Although adherence to IBD therapies is associated with improved clinical outcomes, overall adherence is poor. Consequently, there is a cri
Externí odkaz: https://doaj.org/article/cb0a5a3986834fd7b06328230af70b96
Zobrazit plný text záznamu
4
EFFICACY OF UPADACITINIB IN PATIENTS PREVIOUSLY TREATED WITH TOFACITINIB FOR THE MANAGEMENT OF ULCERATIVE COLITIS
Autor: Marlana Radcliffe, Millie Long, Edward Barnes, Hans Herfarth, Jonathan Hansen, Animesh Jain
Publikováno v: Gastroenterology. 164:S104-S105
BACKGROUND Tofactinib is a JAK inhibitor that targets mainly JAK 1 and JAK3 approved to treat Ulcerative Colitis (UC) in 2018. The JAK inhibitor Upadacitinib (upa) was recently approved to treat UC in March 2022 and has increased selectivity for JAK1
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::465b7ee9cc397f52760889b1d68894ef
https://doi.org/10.1053/j.gastro.2023.03.200
Zobrazit plný text záznamu
5
IMPROVEMENT IN BOWEL URGENCY IS ASSOCIATED WITH STOOL FREQUENCY AND RECTAL BLEEDING REMISSION AT 12 AND 52 WEEKS IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS
Autor: Millie Long, Javier Gisbert, Kim McGinnis, Marc Ferrante, Gerhard Rogler, Christophe Sapin, Theresa Hunter, Joe Milata, Seyedehsan Navabi
Publikováno v: Gastroenterology. 164:S13-S14
INTRODUCTION Mirikizumab, an anti-IL23p19 antibody, has demonstrated safety and efficacy versus placebo across clinical remission, symptomatic remission, and endoscopic and histologic endpoints in patients with moderately-to-severely active ulcerativ
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2da95fe70be8a9b8ea8a761b6b6636d7
https://doi.org/10.1053/j.gastro.2023.03.033
Zobrazit plný text záznamu
6
Exposure to corticosteroids in pregnancy is associated with adverse perinatal outcomes among infants of mothers with inflammatory bowel disease: results from the PIANO registry
Autor: Florence-Damilola, Odufalu, Millie, Long, Kirk, Lin, Uma, Mahadevan, Vinita, Jacob
Publikováno v: Gut. 71:1766-1772
ObjectiveActive inflammatory bowel disease (IBD) during pregnancy may require the use of corticosteroids. The aim of this study was to investigate the impact of in utero corticosteroid exposure on adverse pregnancy outcomes, congenital malformations,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::382882cf1b059a2e4334052e69c93f70
https://doi.org/10.1136/gutjnl-2021-325317
Zobrazit plný text záznamu
8
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence with Inflammatory Bowel DiSease Therapy—ASSIST Study: A Randomized Controlled Trial (Preprint)
Autor: Jordan Axelrad, Millie Long, Sara Horst, Anita Afzali, Tamar Sapir, Kristina Fajardo, Kara De Felice, Robert Sandler, Raymond Cross
BACKGROUND Inflammatory bowel diseases (IBD) are chronic inflammatory conditions of the gastrointestinal tract often requiring long-term medical therapy. While adherence to IBD therapies is associated with improved clinical outcomes, overall adherenc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ac6026e5c3674755208c064c5e1bcfdf
https://doi.org/10.2196/preprints.40382
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje